Safety-Related Labeling Changes

Thrombotic microangiopathy , haemolytic uremic syndrome

Trade Name

Rifadin

Updated Section

"4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects"

Month

Feb,2023